Sentinel Lymph Node Biopsy: Understanding the Procedure & Benefits
Sentinel lymph node biopsy (SLNB) identifies the first node(s) draining a primary tumor—most commonly used in breast cancer and melanoma.
Procedure
- Injection of radioactive tracer (technetium‑99m) and/or blue dye (isosulfan blue) near the tumor.
- Lymphatic mapping: gamma probe detects radioactive nodes; blue dye provides visual guidance.
- Excision of 1–3 sentinel nodes for intraoperative frozen section or permanent pathology.
Interpretation
- Negative nodes: Low likelihood of regional spread; may avoid complete lymphadenectomy.
- Positive nodes: Indicates nodal metastasis; completion dissection or adjuvant therapy considered.
Benefits
- Reduces morbidity (lymphedema, nerve injury) vs. full dissection.
- Accurate staging guides adjuvant treatment decisions.
- Outpatient procedure in most cases.
Lymphoma - Related Articles
- Lymph Organ Functions: Correct Matchings
- Lymph Node Cancer Prognosis: Understanding Survival Rates & Early Treatment
- Mature vs. Maturing Lymphocytes: Stages of Immune Cell Development
- Understanding Lymphoma: Symptoms, Types & What to Expect
- Lymphatic System and Disease: Role in Pathogen and Cancer Spread
- Lymphatic Circulation: Anatomy, Flow & Immune Function
- Lymphocytes: B-Cells and T-Cells in Adaptive Immunity
